Clinical Trial Update: Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases [NA]

View source ↗

Summary

This clinical trial update reports on reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for malignant hematologic diseases, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Snippet

Sponsor: University of Oklahoma | Conditions: Hematological Neoplasms, Hematopoietic Stem Cell Transplantation | NA | Status: COMPLETED | Results posted: 2011-04-22